- Country: Ukraine
- Summary: Atropine Sulfate Drops. Eye 10 Mg/1 Ml in 5 Ml. in a Bottle, Tropicamide Eye Drops 10 Mg/Ml 10 Ml No. 1, Pilocarpine Eye Drops 10 Mg/Ml 10 Ml, Levofloxacin Eye Drops Solution 5 Mg/Ml Bottle 5 Ml, Oxyb...
- UAT Ref No: 131603035
- Deadline: 08 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 1818909
- Notice Type: Tender
- Document Ref. No.: UA-2025-12-03-015941-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Atropine sulfate drops. eye 10 mg/1 ml in 5 ml. in a bottle, Tropicamide eye drops 10 mg/ml 10 ml No. 1, Pilocarpine eye drops 10 mg/ml 10 ml, Levofloxacin eye drops solution 5 mg/ml bottle 5 ml, Oxybuprocaine eye drops, solution 0.4%, 10 ml each dropper containers, Amoxicillin/clavulanic acid film-coated tablets, 875 mg/125 mg each, Acetazolamide, tablets, 250 mg each, Pancreatin, lipolytic units: 8000, Amikacin, solution for injection, 250 mg/ml 4 ml (1000 mg), Amoxicillin and clavulanic acid acid, powder for injection/infusion 1.2 g,Cefepime, powder for injection, 2.0 g,Octreotide solution for injection 0.1 mg/ml in 1 ml,Nadroparin, solution for injection, 9500 IU anti-Xa/ml in 0.4 ml,Noradrenaline, concentrate for solution for infusion, 2 mg/ml in 8 ml, Haloperidol, solution for injection, 5 mg/ml, 1 ml each, Valproic acid, tablets, 500 mg each, Thiamine chloride (vitamin B1), solution for injection, 50 mg/ml, 1 ml each, Salbutamol, inhalation under pressure, 100 mcg/dose, 200 doses each, Risperidone, tablets, 4 each mg, Chloropyramine, solution for injection, 20 mg/ml, 1 ml each, Levocetirizine, tablets, 5 mg each, Trazodone tablets 100 mg, Trazodone tablets 150 mg, Duloxetine capsules 30 mg Type of procurement: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products 1. TX of the product in accordance with the product specification, formed by the administrator of the electronic catalog. The contract is filled out and submitted in paper form by the winner within the terms recognized by law to the Customer's postal address Name Classifier and its corresponding code Quantity/Measurement units Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products 1. ТХ of the product in accordance with the product specification formed by the administrator of the electronic catalog. Contract is filled out and submitted in paper form by the winner within the terms recognized by law to the Customer's postal add...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAtropine Sulfate Drops. Eye 10 Mg/1 Ml in 5 Ml. in a Bottle, Tropicamide Eye Drops 10 Mg/Ml 10 Ml No. 1, Pilocarpine Eye Drops 10 Mg/Ml 10 Ml, Levofloxacin Eye Drops Solution 5 Mg/Ml Bottle 5 Ml, Oxyb... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "KYIV CITY CLINICAL HOSPITAL № 8" OF THE EXECUTIVE BODY OF KYIV CITY COUNCIL (KYIV CITY STATE ADMINISTRATION), a Government sector organization in Ukraine, has announced a new tender for Atropine Sulfate Drops. Eye 10 Mg/1 Ml in 5 Ml. in a Bottle, Tropicamide Eye Drops 10 Mg/Ml 10 Ml No. 1, Pilocarpine Eye Drops 10 Mg/Ml 10 Ml, Levofloxacin Eye Drops Solution 5 Mg/Ml Bottle 5 Ml, Oxyb.... This tender is published on UkraineTenders under UAT Ref No: 131603035 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-08.
The estimated tender value is UAH 1818909, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
